CCL11 and asthma: eCOPD patients could be distinguished from the severe asthma group by enhanced IL-4 levels (Table 3, Figure 4A) and reduced serum levels of eotaxin-1 and sFcεRI (p < 0.05) (Table 3, Figure 4E,F).